MORTIMER IAN (PRESIDENT & CFO) sold 80.8% of their position (25.20K shares) of XENON PHARMACEUTICALS INC. on the open market
Open‑market sale worth $1.14M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 12/9/2025ACC: 0001193125-25-313147
Officer· PRESIDENT & CFO
Since Sep 2019
-25.20K
Net shares
Net seller
$1.14M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
25.20K disposed
Non-Derivative Transactions3
Common Shares
Direct
Shares
−14.38K
Price / share
$45.03
Trade value
$647.31K
% of position
46.1%
12/5/2025
31.20K→16.83K
Common Shares
Direct
Shares
−8.82K
Price / share
$45.59
Trade value
$402.10K
% of position
52.4%
12/8/2025
16.83K→8.01K
Common Shares
Direct
Shares
−2.01K
Price / share
$46.32
Trade value
$93.10K
% of position
25.1%
12/8/2025
8.01K→6K
Total
Net shares
−25.20K
Net value
-$1.14M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 12/5/2025 | S · Sale | −14.38K | $45.03 | $647.31K | 46.1% | 31.20K | 16.83K |
| Common Shares Direct | 12/8/2025 | S · Sale | −8.82K | $45.59 | $402.10K | 52.4% | 16.83K | 8.01K |
| Common Shares Direct | 12/8/2025 | S · Sale | −2.01K | $46.32 | $93.10K | 25.1% | 8.01K | 6K |
| Total | −25.20K | -$1.14M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Shares
IndirectShares owned14.30K
Total
14.30K indirect14.30K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 14.30K | Indirect |
| Total | 14.30K | 14.30K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported